您的位置: 首页 > 农业专利 > 详情页

Alkyl piperazine compounds
专利权人:
GENENTECH; INC.
发明人:
申请号:
ARP120104129
公开号:
AR088642A1
申请日:
2012.11.02
申请国别(地区):
AR
年份:
2014
代理人:
摘要:
What is provided is a rented agent for the treatment of flammability, autoimmunity and cancer. Claim 1: a compound (1) selected from the formula,Or its stereoisomer, Dow agent or salt acceptable for drug:R2 and R3 were selected independently from h, F, Cl, - nh832222;-NHCH₃,-N (CH)-Oh, oc832323,-8 832283;-OCH₂CH₂OH and C₁₋₃ alkyl;R830808 is from h, F, Cl, CN, - ch8322; - Oh, - CH (ch832323) Oh, - C (ch832323) 8322; - H (cf832323) Oh, - ch8322;; F, - chf832222;-CH₂CHF₂,-CF8323,-C (O) NH-C (O) NHCH-C (O) N (CH)-NH832222,-NHCH₃,-N (CH)-NHC (O) CH-Oh, oc832323,-8 832283;-Och 8322; - ch8322oh, cyclopapilor, cyclopapilmet, 1-hydrocyclopapler, imidazolilo, pirazolilo, 3-hydroxi-oxitan-3-ilo, oxetan-3-ilo and azetidin-1-ilo; r83099, selected from - ch832323;-CH₂CH₃,-CH₂OH, -CH₂F, -CHF₂,-CF8323,-Cn y-ch8322; - ch83222;; or two r83099 groups form a carbon cycle or heterocycle of 3, 4, 5 or 6 members; or one r83099 and r831222 group form a carbon cycle or heterocycle of 3, 4, 5 or 6 members; N group is 1, 2, 3 or 4; r8310 group is selected from h-ch832323;-CH₂CH₃,-Ch832228; - nh83222y-oh; r8311811 are selected from the structure of the preparation group (2),a. Corrugated line indicates connection point; r831222 is selected from - ch832323;-S (O) CHe. Cyclopentadiene, azetin-3-ilo, oxetan-3-ilo and morfolin-4-ilo; X1 is cr8313o n, selected from h, F, cl-ch-832313;-CH₂CH₃,-CH CH OH -NH-NHCH₃,-N (CH)-Oh, oc832323,-OCH₂CH₃ and -OCH₂CH₂OH; X² is CR¹⁰ or N, where R¹⁰ is selected from H, -CH₃,-Ch832228; - ch8323y-ch832228; - ch832228; - Oh; Y1 and Y2 are independently selected from CH and N, where y and N are not each n.Se proporcionan compuestos alquilados de piperazina, usados como medicamentos útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y cáncer. Reivindicación 1: Un compuesto seleccionado de la fórmula (1), o sus estereoisómeros, tautómeros o sales farmacéuticamente aceptables, en donde: R¹, R² y R³ están seleccionados, de modo independiente, de H, F, Cl,
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充